Health & Nutrition

bg
Weight loss and hair loss: The growing hair treatment market from GLP-1s

Weight loss and hair loss: The growing hair treatment market...

A common side effect of many GLP-1 drugs is hair loss. It's creating a formerly...

bg
Cardinal Health's sell-off on earnings was an overreaction. We'd be buyers

Cardinal Health's sell-off on earnings was an overreaction....

Our rationale for owning Cardinal Health remains intact.

bg
Quest Dill Pickle Deviled Eggs Recipe

Quest Dill Pickle Deviled Eggs Recipe

Back in the day, ‘deviled’ meant something had a little kick – mustard, spice, tang,...

bg
Quest Dill Pickle Protein Waffles Recipe

Quest Dill Pickle Protein Waffles Recipe

Waffles, traditionally, are a sweet situation. Syrup. Butter. Maybe fruit gets a...

bg
Eli Lilly shares surge on a beat-and-raise, proving the stock's swoon was a mistake

Eli Lilly shares surge on a beat-and-raise, proving the...

Eli Lilly entered Thursday well off its highs. A blowout quarter shows the market...

bg
Trump taps Nicole Saphier for surgeon general after pulling Casey Means nomination

Trump taps Nicole Saphier for surgeon general after pulling...

Means' nomination had stalled in the Senate over concerns about her controversial...

bg
More than 20,000 people are taking Eli Lilly's weight loss pill Foundayo, CEO says

More than 20,000 people are taking Eli Lilly's weight loss...

Eli Lilly's weight loss pill launch has been closely watched after the successful...

bg
FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

FDA proposes excluding Novo, Lilly weight loss drugs from...

If that proposal is finalized, the exclusion would likely limit the mass compounding...

bg
NDMA: A Cancer-Causing Contaminant in Meds and Meat

NDMA: A Cancer-Causing Contaminant in Meds and Meat

Billion-dollar drugs have been pulled from the market for less carcinogenic contamination...

bg
Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

Merck beats quarterly estimates on strength of Keytruda...

Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.